Astellas Pharma Inc. (4503) Earnings Call Transcript & Summary
February 17, 2023
Earnings Call Speaker Segments
Hiromitsu "Hiro" Ikeda
executiveThank you very much for joining Astellas' Sustainability Meeting out of a very busy schedule today. I'm serving as MC. My name is Ikeda from Corporate Advocacy & Relations. Thank you for your time. [Operator Instructions] Thank you for your understanding. Today, we have Dr. Kenji Yasukawa, Representative Director, President and CEO; Outside Director, Mamoru Sekiyama; Outside Director, Eriko Sakurai; Chief People Officer and Chief Ethics and Compliance Officer, Katsuyoshi Sugita; and Vice President, Head of Sustainability, Shingo Iino. We are going to explain based on our meeting materials posted on our website. This material or presentation by representatives of the company under answers and statement in the Q&A session includes forward-looking statements based on assumptions and beliefs in light of the information currently available to management and subject to significant risks and uncertainties. Actual results may differ materially depending on a number of factors. They contain information on pharmaceuticals, including compounds under development, but this information is not intended to make any representations or advertisements nor provide medical advice of any kind. Yasukawa-san, please.
Kenji Yasukawa
executiveGood afternoon, everyone. I am Yasukawa. Thank you for taking time out of your business scheduled to attend Astellas' Sustainability Meeting today. The Slide 2, this is a cautionary statement as usual. Since Ikeda already explained this earlier, I will rather skip the reading of this. Last year was the very first time we had this event, and we introduced a wide range of Astellas' initiatives on ESG. Today, I would like to deep dive the progress of our sustainability activities over the past year, with a particular focus on Astellas' unique initiatives and those that have attracted a great deal of interest from the stock market community. I will begin by explaining Astellas' materiality matrix and sustainability direction. Page 4. Last fiscal year, we revised the materiality matrix and selected 19 issues as important issues for Astellas and identified 9 of them as most important issues, in other words, materialities. In this fiscal year, we have summarized them as 2 pillars to help our stakeholders understand how our efforts to address the 9 most important issues will lead to the improvement of our corporate value. The first pillar is transforming to be a cutting-edge, value-driven life science innovator. We will continue to create innovative health care solutions for unmet medical needs, utilizing new modalities such as cell and gene therapy, while striving to ensure that the value we create reaches the patients who need it most. In order to create innovative therapeutic methods continuously, appropriate price setting is necessary for the innovation. Astellas will also work to create an environment and a mechanism to ensure that the prices fairly reflect the impact on society, including patients, their families and the health care professionals who support patients' health. And because we believe that one of the most important driving forces for the creating and delivering significant value to societies is an organizational culture that generates innovation, we will work to foster an organizational culture at Astellas and acquire and develop people that will contribute to the creation of innovation. The second pillar is to strengthen resilient and sustainable business operations to meet the expectations of society. We will build a robust system throughout our supply chain to manufacture products of superior quality to global standards and deliver highly safe products to patients under any circumstances. In addition, we will continue to provide information to ensure that Astellas products are used properly and appropriately by patients. And also while ensuring compliance with laws and regulations in our all business activities, we will meet the expectations of society by considering what health care solutions for patients and what Astellas products can contribute to patients through continuously working our activities in an ethical manner. Astellas has established a sustainability direction as a guide toward FY 2025 to address 9 most important issues and 2 important issues related to the environment that is highly demanded by society. Astellas' sustainability initiatives will be promoted in line with the newly-formulated sustainability direction. The details of the sustainability direction will be explained later by Iino, our Vice President, Head of Sustainability. Now, Page 5. This is a summary of our progress on the items for which we perceive stock market expectations to be high, which we presented at the last sustainability meeting. First of all, regarding KPIs for sustainability initiatives, we have newly established our commitments for 2025 as our mid-term goal for the most important and important issues identified in the materiality matrix. Again, Iino will discuss this in detail later. In addition, we plan to incorporate the sustainability indicators into compensation for directors and officers from FY 2023. I will explain it on the next slide into more details. We have proactively disclosed information regarding sustainability through upgrading the sustainability section on corporate website and the publication of our first integrated report. The ratio of female managers increased from the previous year both globally and in Japan. The ratio of female Board members also increased to 30%, with the addition of 2 new female directors last year. While continuing to emphasize diversity, we will consider the optimal composition of the Board of Directors in terms of skills and past work experience. We are pleased to have Outside Directors, Sekiyama-san and Sakurai-san here with us. With regards to the dialogue with the external directors, we would like to continue to set up opportunities for direct dialogue with the stock market community. Regarding the declaration of net zero goal, we obtained SBT certification in November for our 1.5 degree Celsius target and our well below 2 degree Celsius target by 2030. And just recently, on February 9, we declared our net zero target by 2050. This is all the progress we have made since the last time. Now, I will explain the incorporation of sustainability measurement indicators into compensation for directors and officers on the next slide. Page 6. As the awareness of the importance of sustainability as an important management issue grows each year, we are planning to add a new sustainability indicator to the incentive targets for directors and officers, with the aim of strengthening governance to improve sustainability. This is scheduled to be introduced in fiscal 2023. Specifically, we are considering adding sustainability performance to the company-wide performance indicators for bonus, which is short-term incentive compensation among variable compensation with a weighting of about 10%, and evaluating it in the following 4 categories: access to health, talent and organization, stable products supply and environmental sustainability. Specific evaluation indicators and methods are currently under consideration. Page 7. Next, I would like to introduce some initiatives related to one of the two pillars of sustainability direction that I presented earlier, strengthening the resilient and sustainable business operations to meet expectations of society. Astellas is strengthening its BCP measures against unpredictable risks such as regional conflicts and natural disasters, and is preparing for supply chain segmentation, energy shortage and rising energy costs. More specifically, in preparation for supply chain segmentation, we adjust inventory levels to maintain stable supply according to risk levels. In addition, we have secured secondary suppliers and secondary sites for many of our global products. To reduce energy-related risks, we are working for the introduction of solar power generation, introducing backup power supplies for manufacturing and research sites in Japan and setting up emergency power supplies. By recognizing and preparing for unpredictable risks, we will maintain a stable supply of pharmaceuticals, which is our mission as a pharmaceutical company, and will realize a flexible and sustainable business. Now, Page 8. The agenda for the rest of this presentation is shown here. First, Iino, Vice President, Head of Sustainability, will introduce Astellas' initiatives, to address sustainability issues and Astellas' commitments until 2025. Next, Sugita, the CPO and the CEO (sic) [ CECO ] or Chief People Officer and Chief Ethics & Compliance Officer, will introduce Astellas' HR goals, specific initiatives and progress. Now lastly, Outside Director, Sekiyama-san, will introduce the efforts and thoughts of outside directors who encourage innovation creation by overseeing our initiatives from an outside perspective. Now Iino-san,, please start.
Shingo Iino
executiveHello, everyone. I am Iino, Vice President, Head of Sustainability. I would like to introduce our initiatives for enhancing sustainability. Page 10. Yasukawa introduced at the beginning of the presentation that the 9 most important issues identified in the revision of the raw material -- in the revision of the materiality matrix were summarized in the 2 pillars to show how addressing them would lead us to the improvement of corporate value. As shown on this slide, the most important issues that comprises the 2 pillars are numbered. This fiscal year still has conducted a gap in opportunity analysis with internal and external stakeholders on the 9 most important issues, as well as on environmental-related issues that are highly demanded by society and identified as specific items that Astellas will prioritize over the medium term, specific initiatives and commitment to those results. These are collectively referred to as our sustainability direction. Due to time constraints, it is difficult to explain all of the issues. So today, I will focus on access to health, that's 1, and 10 and 11, the environmental sustainability, and explain them in detail. The details of our initiatives to address the other issues are provided on Pages 36 to 38 of the appendix. Page 11. I will begin by explaining access to health, the 1, using this slide and the next slide -- next 2 slides. The left side shows Astellas' midterm priorities and the most important issue of access to health. The center of the slide shows specific initiatives, and the right side shows our commitments by FY '25. In the center of the circle at the bottom of the slide, the first is Astellas' core business, and the second is enhancing the availability of Astellas products, for which we are working to maximize patient access to the innovations we create. And in order to improve outcomes for patients, we will provide comprehensive access programs throughout the product life cycle. And by FY '25, we will provide as many patients as possible with access to our products. The outermost third cycle is to support the strengthening of health care systems through external partnership such as NPOs and Astellas-affiliated foundations to improve disease awareness, prevention and access to health care services. And we aim to impact more than 36 million people by FY '25 through various forms of support. The next slide shows our performance against this commitment. Page 12. First, in -- 1 in circle, the performance related to Astellas' core business. Astellas has impacted approximately 143 million people in 103 countries in the first half of FY '22, further prescribing of Astellas products. Next, 2 in circle shows the number of patients supported by various access programs throughout the entire life cycle for those patients who cannot be reached by our core business alone. Our drug access strategy has impacted a certain number of patients from the development stage. We do not set quantitative targets for these figures, but we will periodically monitor and disclose the progress of our efforts. The third, supporting third-party access through health activities and foundations. We have just provided you with a quantitative target of impact in more than 36 million people. This target measures the impact on the activities of health system strengthening program and Astellas Global Health Foundation, which is circled in red. We will continue to implement Astellas' unique access improvement initiatives. Page 13. Next, I will explain about reduction of environmental burden and climate change and energy on this slide. As shown in the figure below, we have set the FY '30 target buyback calculating with the goal of 2050 zero greenhouse gas emissions. The 2 degrees Celsius target for which we obtained SBT certification in 2018 was achieved ahead of schedule in FY '21, so we set a new target last year and obtained SBT certification. More specifically, we are targeting a 63% reduction in Scope 1 plus 2 GHG emissions with a 1.5 degrees Celsius target in mind and a 37.5% reduction in Scope 3 emissions with a well below 2 degrees target in mind. Currently, we are considering the active use of the renewable energy resources, including the installation of solar panels at our Toyama and Tsukuba area and overseas at our Kerry plant in Ireland, as well as the update of wind power generation equipment. We will also work to reduce the GHG of our supply chain. Now Page 14. The information presented today is available on our corporate website. We will also disclose and update the progress of our commitment by FY '25 as needed. By focusing on the 2 pillars of our sustainability direction introduced earlier, aiming to achieve sustainability for both society and Astellas, in other words, sustainability transformation, we will continue to improve our corporate value by having all employees work together to address key issues and materiality. We would like to enhance the disclosure of information on Astellas' initiatives to improve sustainability and continue to hold dialogues with our stakeholders. Next, Sugita-san, CPO and CECO, will explain about people and organization. Sugita-san, please.
Katsuyoshi Sugita
executiveThank you. Hello, everyone. I am Sugita, CEO and CECO. I would like to explain about Astellas' people and our organization. Now Page 16, please. I would like to focus on 3 unique features of Astellas' human resources. First, we carefully select initiatives that focus on achieving organizational health goals, which are directly linked to achieving CSP 2021. Astellas' HR exists to contribute to the business. For example, HR business partners who support the business growth of each division in terms of people and organization are required to participate in the management meetings of their assigned division's organization and contribute as a member of the management team. Next, to support Astellas' worldwide business, we are building a global HR policy. HR is a single division overseeing both Japan and overseas, and the chain of command is unified. Astellas does not manage people according to seniority or year of employment, and rather promote them on a global basis. We are aiming at being a data-driven HR organization. We use all kinds of data, including business and organizational data, to ensure that we are making progress and sharing this information with each organization. In the future, we intend to proactively disclose data related to the organization not only internally, but also externally. The end, what is important here is that actual culture transformation is promoted not by Astellas' HR, but by leaders in each division. And Astellas' HR is a coach of personal development and organizational transformation. That is the definition we have. Now Page 17. As I mentioned earlier, Astellas' HR priorities are those that are directly related to the achievement of CSP 2021, and by extension, the realization of the vision. There are 3 priorities for HR. The first is the organizational culture and mindset transformation. The second is the developing global or HR policies that supports our people in our organization. And the third is transforming the organization into an innovation engine. The foundation for all of these is monitoring of the progress through reliable and a data-driven approach. The next slide will introduce the 3 priorities shown here and our specific initiatives regarding monitoring of the progress through reliable and a data-driven approach. Page 18. Here is an example of our approach to culture and mindset transformation, one of the HR priorities I mentioned earlier. In order to encourage employees to grow through smart risk taking and learning based upon that, we are focusing on ensuring psychological safety and promoting our culture of feedback. At Astellas, we believe that an organization with psychological safety is one in which people trust each other and communicate openly. To create an organization that continues to generate innovation, it is important to have an environment where everyone can share how bold ideas without a fear of consequences, challenge the status quo and give each other feedback and also a mindset where feedback from others leads to personal growth, and feedback from others really contribute to the growth of each. With this in mind, we introduced a company-wide feedback tool in October 2022 to promote a feedback culture. The tool enables timely exchange of feedback not only from superiors to subordinates, but also among all levels of employees. And so far, 4,324 pieces of feedback have been exchanged so far throughout the world. In addition, Ask Me Anything and Live Stream interactive sessions have been developed to promote 2-way communication between top management and employees. At the last sustainability meeting, we introduced Ask Me Anything. So this time, I would like to introduce you Live Stream, which is newly added this time. Live Stream is a live session in which all top management participates. The session is a place for top management to openly share their thoughts and experiences on a theme decided each time. The experience stories are not about glory or success, but rather about failures and also the reflections that is gained from their experience in the past, and the lessons learned from these experiences are actively shared from the top management. This is well accepted, and the first one, approximately 7,000 employees participated in the first session and 6,500 in the second session so far. Page 19. Another initiative for culture and mindset transformation is our global leadership program that I'd like to introduce here. Astellas believes that capacity building at the management level is key, and we are focusing on such development. As a symbolic initiative, we have developed the Astellas Leaders' Summit and the Quarterly Leader Forum in FY 2022. The Astellas Leaders' Summit is designed to show the understanding of current situation from top management and discuss strategies to achieve the CSP 2021. This year, all top management and global division heads were invited to Tokyo. The 3-day meeting was fully utilized, and deep and dedicated, detailed discussions were held as only face-to-face meetings can. I feel that this has further strengthened not only our understanding of strategy, but also our sense of unity. As leaders, the leaders need to think about the company as a whole. I think that is reinforced here. Another point I would like to make is the Quarterly Leader Forum, which is aimed at developing leaders. The goal is to develop leaders who can create a corporate culture that generates new ideas and drive the culture transformation. The forum is held once a quarter and targets approximately 550 executive directors, vice presidents and above, and has been held 3 times so far in FY '22. The third session featured a lecture by Professor Gary Pisano of the Harvard Business School, and we are working to develop leadership skills by incorporating a great deal of outside knowledge. On Page 20, I will introduce the second priority of Astellas HR, developing global HR policies that support our people and organization. As was mentioned at the beginning, Astellas' business is expanding globally. If you look at FY 2021 net sales by region, Japan accounts for about 20% of the total while overseas market account for about 80%. Along with the globalization of our business, our employee composition is also globalizing. In FY 2021, non-Japanese employees account for 66% of the total workforce. A similar trend is seen also at the management level. As of the first of April 2023, 3 out of 9 management executives are non-Japanese. More than half of the division heads, one layer below the management, are non-Japanese employees. So management level meetings are all conducted in English at Astellas without using interpreters. Global collaboration is necessary in our day-to-day work in this environment. Next, Page 21. Earlier, I talked about the globalization of our human resources, including employees as a whole, the top management and division heads as an example. Here, I'd like to talk about the creation of succession plans by job grade. At Astellas, we focus on the creation of succession plans for important positions. We roll out initiatives to build up a diverse workforce also for positions below VP. In FY 2022, non-Japanese employees account for 57% of the 178 positions above Executive Director. Out of the 522 employees selected as successful candidates, 43% are non-Japanese employees and 36% are female employees. As we have diverse talent in our succession planning, we are expanding the creation of succession plans also to positions above Senior Director as well. In FY 2022, employees -- non-Japanese employees account for 68% of the 238 positions, while 38% of the 551 successor candidates we are securing are non-Japanese employees and 42% are female employees. Also, at this level, in this layer, we have a diverse talent in our succession planning. So in this way, Astellas is already selecting human resources regardless of the nationality and gender. Based on the philosophy of the right people in the right position, we will continue to select the best people from the talent around the world as successors. Next, Page 22. As another initiative to develop global HR policies that support our people and organization, we have integrated global talent management process around the world. First, we revised our objective setting and evaluation systems. For divisions, we set cross-functional objectives not close to each division. For individuals, we promote ambitious objective setting and the launch of our feedback tool. We are aiming to enhance our performance as one Astellas, one team. We also revised our rewards and recognition system. We changed the calculation factor of bonus payment amount from divisional performance to company-wide performance by now, as a basis. In addition, we are planning to launch recognition program. The integration of the job grading system was already explained in the previous sustainability meeting, so I will skip its details today. As a foundation to support these pillars and realize the right people in the right position on a global basis, we are promoting the global integration of HR system. By leveraging technologies proactively, we are aiming to provide services in a faster and smoother fashion and allocate resources through innovative activities. Next, on Page 23, I'd like to talk about the third priority of Astellas' HR, transforming the organization into an innovation engine. We believe that organizational flattening is essential in order to build an environment that encourages innovation. These layers are the better for the organization in our view. To promote fast decision-making, we are promoting the transformation of each organization by reducing the number of layers from the CEO to be 6 or less in principle. We are promoting the transformation of each organization in this way. In the coming April, we have been making a lot of efforts. So in April, 82% of all the departments are expected to achieve this target of 6 or less layers. Furthermore, the span of control, the number of members that one people manager manages, should be 6 or more in principle. The average of all departments as of April 2022 was 5.2, but is expected to reach 6.1 next April after a year, so there's going to be a substantial improvement we're expecting. This is not something we can achieve overnight, but with a strong will to achieve this by all means, we will continue the transformation of organization towards April and beyond. On Page 24, I'd like to talk about monitoring the progress through reliable and data-driven approach, which is the foundation for Astellas' HR initiatives. We are promoting organizational optimization and fostering the sense of ownership through the visualization and sharing of organizational data by using the data-driven approach. We are working in this direction. As one of such specific initiatives, we released HR Leadership Dashboard. As is shown in the sample image, various data is visualized such as personnel structure, composition, the status of hiring and termination, the span of control, the size of the teams, et cetera, in the organization. You can see such data in the dashboard. By looking at the organization from every angle, it is possible to recognize issues you may not notice just by looking at individual data and to share the whole picture to take next steps or action. What's important here is that nothing will happen just by having a tool. How to leverage the tool to bring about useful insights is important. So within HR, we are working on capability development so that we can utilize this to draw useful insights with strategic perspectives. On Page 25, let me talk about our global engagement survey as another initiative to monitor the progress through reliable and data-driven approach. At Astellas, we conduct company-wide survey in order to visualize employees' engagement, identify organizational issues and come up with measures to make improvement. We have been rolling this out globally since FY 2017 in the entire company. In the past, global engagement survey was conducted once every 2 years, but has been implemented once a year since last year. We are using the tool, fully leveraging technologies. We visualize scores for each item and perform trend analysis of comments with AI. By analyzing this in combination, we can identify our organizational strength and opportunities to improve. On the slide, you can see an overview of the results of the October 2022 survey. 82% of all employees responded. 75% of answers to the questions showed improvement compared to the previous fiscal year, according to the survey results. We will continue to focus on the top 3 items based on the scores as a strength, so we'd like to maintain these strengths. On the other hand, with regards to the bottom 3 items, other opportunities to improve, we are taking specific action aiming for a better workplace environment and enhanced engagement. We will check the results of these initiatives in the next survey and run the PDCA cycle. Next, Page 26. At Astellas, we are also analyzing the survey results for each category of organizational health goals. Compared to January 2022, we confirmed improvement in many items according to the October survey results. We will continue to monitor progress against organizational health goals in the survey, which we consider are very important in CSP 2021 and disclose the progress every year. I skip explaining the details verbally, so please refer to Page 40 to 42 in the appendix for the results for each item in more detail. Next, Page 27. In today's sustainability meeting, we are sharing our priorities to achieve CSP 2021. We will continue to concentrate on what we can specifically contribute to the long-term success of Astellas for the future as well. We will advance frameworks and processes that can be applied globally and take data-driven actions proactively one after another. We will continue to make efforts to be a leading company in HR not only in Japan, but also globally as well. We'd like to engage in internal and external messaging and dialogue more actively. We appreciate continued support from you as our stakeholders. In the last section, Mr. Mamoru Sekiyama is going to explain Astellas' corporate governance from an outside director's perspective. Mamoru Sekiyama-san, please.
Mamoru Sekiyama
executiveHello, everyone. I'm Sekiyama, Outside Director. I'm joining this meeting as an outside director for the first time today. I have been looking forward to this occasion as a precious opportunity of direct dialogue with you as our external stakeholders. I'm going to explain how I see Astellas' governance in my capacity as an outside director and talk about specific activities so far and future contributions. Next, Page 29. Today, another Outside Director, Ms. Eriko Sakurai is also attending with me. She will answer your questions during the Q&A session later. You can find our resumes on this page. I was appointed as an Outside Director, the Chairperson of the Nomination Committee and the Chairperson of the Compensation Committee in June 2017. This is my sixth year in these positions. Ms. Sakurai was appointed as an Outside Director in June last year. She's a member of the Nomination Committee and the Compensation Committee. Page 30, please. This page shows major events are experienced since I assumed the post of an Outside Director at Astellas. After I was elected as an Outside Director in June 2017, there was a major governance-related event. In June 2018, Astellas transitioned to a company with Audit and Supervisory Committee, which enables the delegation of a substantial part of the Board of Directors' decision-making authority of the execution of business to executive directors. In this way, the Board of Directors are working to further enhance discussions on corporate strategies, et cetera, and further strengthen the supervisory function of the Board of Directors. As is shown at the bottom of this page, Astellas announced two corporate strategic plans since my appointment. I will touch on this later, but upon CSP development, there were deep discussions with the executive team. We made recommendations about including sustainability enhancement and strategic goals in CSP 2021. Since my appointment, I was involved with the decision to change the President and CEO twice and a comprehensive revision of the compensation system for directors and officers. On the next page, I'd like to talk about the main activities I have worked on from both Nomination and the Compensation Committee's perspectives. Page 31. As I mentioned earlier, I have been chairing the Nomination Committee and the Compensation Committee since 2017. Through active communication with the executive team and appropriate information collection, we ensure and maintain high governance functions through transparent and objective committee operations, mainly by outside directors. I think this is our strength. At present, both committees consist only of outside directors as members. Here, I'd like to explain some of the activities by now. First, on the left-hand side of this page, three points are described as activities of the Nomination Committee. First, the committee stipulated standards for the appointment of President and CEO. Even prior to my appointment, the Nomination Committee had rounds of discussions on how to stipulate the appointment standards. The appointment standards were stipulated in the internal policy in FY 2017 after I took office. I remember that the appointment standards were also disclosed externally in the following year, FY 2018. The most important responsibility of the Nomination Committee is to deliberate on the reappointment of the President or the selection of a new President. In order to have such discussions, it's very important to put into place the appointment standards. As is described in the second bullet point, it's also important to ensure good preparation for succession planning. Regarding the succession planning for the CEO, the Nomination Committee has confirmed and discussed the status of successors every year from before. We expanded deliberations on succession planning also for top management positions as well. As for the third point, it's also our important responsibility to search for outside director candidates, in particular, and discuss the selection in order to achieve an optimal board composition. This fiscal year, we have been able to welcome 2 female directors, including Ms. Sakurai, who is attending today. But securing candidates is becoming more challenging every year, so the Nomination Committee is also trying to have earlier deliberations. Next, I will explain the activities of the Compensation Committee shown on the right. As a major event, I'd like to mention the overall revision of the compensation system for directors and officers, how to address the challenges that have emerged with the globalization of the business. Over the course of a year or so, the Compensation Committee had held numerous discussions and revised the overall compensation system in FY 2019. When we discussed the new compensation system, recommendations were made by the consensus of the Compensation Committee that we should be accountable to stakeholders to explain why we need to revise the system now, and that we should further promote information disclosure regardless of the conventional habits and practices. The then Board Chairperson, Hatanaka-san; President and CEO, Yasukawa-san; and the Board were of the same opinion, so this was handled with sincerity, which I believe was well understood by stakeholders as well. As a recent activity, as Dr. Yasukawa explained earlier in his presentation, the Compensation Committee is discussing incorporating sustainability initiatives into indicators to assess bonus payment from FY 2023. I think recommendations from outside directors were one of the triggers for this movement. On Page 32, I will explain the activities of outside directors on the Board, other than the activities of the Nomination and the Compensation Committees I mentioned before. You can find actual suggestions and requests from outside directors by now on the left, and the items of -- impacted by those recommendations and requests on the right. First, we requested information sharing that is necessary for the supervision of the company's management. Of course, there was already information sharing by then, but by enhancing information sharing from the executive team, the Board of Directors can conduct deeper discussions based on appropriate understanding. Examples of items with deeper discussions were shown on the slide. Next, as I mentioned before, I was involved in the discussions of two corporate strategic plans. In CSP 2021, we made a suggestion to include sustainability as one of the strategic goals to show not only our achievement, but also the linkage between these efforts and enhancement of corporate value. As you know, this led to the setting of strategic goal for deepening our engagement and sustainability in CSP 2021. This is related to the first point, and we asked the executive team to share the content of the dialogue with various stakeholders and accept outside directors' advice to reflect stakeholders' opinions. I believe this has led to the organization of the first sustainability meeting and the issuance of integrated reports. On Page 33, my last page, I'd like to talk about future contributions and ideas from outside directors. Three main points are listed on this page. First, appropriate monitoring to achieve CSP 2021. We, outside directors, will contribute from a point of view and position different from the executive team towards the same goal of achieving CSP 2021. Specifically, we will make proactive recommendations for the realization of strategies and facilitate swift decision-making that encourages intelligent risk-taking. There are also opportunities for outside directors to discuss in advance with the executive team the content of financial results, explanations to external shareholders so that outside directors' opinions will be reflected. The second point is to support the organization's change in becoming agile and flexible. Astellas is continuing to make agile and flexible changes in response to internal and external environmental changes, not sticking to conventional system and habits. So we, as outside directors, will adequately supervise and encourage these changes. Regarding the promotion and change of the initiatives, we will request to the executive team for any information thought necessary for the supervisory role. We will advise from different perspectives, taking advantage of the experience and knowledge of each outside director. And the third is our wish to expand opportunities for dialogue with diverse stakeholders. We will consider with the executive team about our participation in investor meetings. We are attending the sustainability meeting of outside directors for the first time today. We will continue our participation in future sustainability meetings as well. We incorporated outside directors' messages in interview formats in the integrated report last year. We think it's important to send information and messages to stakeholders from outside directors for a better understanding of our company. We will engage more proactively and adequately in our capacity as outside directors in order to achieve CSP 2021 and realize our vision. That's all for me. Q&A session will be joined also by Sakurai-san, an Outside Director. We will respond to your questions as outside directors. Thank you very much.
Unknown Executive
executiveThank you so much. This is a further explanation from our end. Now, we would like to entertain your questions.
Operator
operator[Operator Instructions] The first question is from Mitsubishi UFJ Trust Bank, [ Mr. Hyogo, ] please.
Unknown Analyst
analystI'm [ Hyogo ] from Mitsubishi UFJ Trust Bank. Compared to the previous year, my impression is that you talked about the reflection of the market opinions to this, for example, the environmental activities. Those are also dealt with. Thank you very much for your hard work. And also sustainability governance, which was not really touched upon this time, so that you can really realize that it will be great if you could deep dive the explanation in that perspective. Now here is my question, this is a question to Sekiyama-san. The simple answer would be acceptable for me. I've been working as the analyst for the pharmaceutical industry, but what I've been thinking this day is that the past investment for the pipelines even, we see the impairment loss for the full base. And after the settlement of the financial term, that is likely to be the part of the discussions. And because of the nature of the business, I think this is unavoidable. And from the perspective of the external directors, I think this is something you are going to support, necessary to be considered. But from the monitoring perspective and the supervising perspective, do you think this situation is completely not problematic? Would you please explain about that?
Mamoru Sekiyama
executiveWell, as for the investment item or transaction, of course, not only about the business perspectives but also the legal aspects, the decision is needed to be made by executive members. But as Board of Directors, when it comes to this issue, we -- within this Board of Directors' meeting monthly, as the business development aspects, we've been receiving the introduction and explanation about those. And in other words, we have opportunities as external directors to express our opinions. And there, such a various opinions are exchanged to decide the new investment. Of course, at the time of introduction, the milestone is set. Of course, certain hurdles for -- with regards to the financial value is introduced to make a final decision. After the investment, you might consider about the necessity of the monitoring. Well, in that aspect, in the quarterly reports, we received the detailed explanation. And also post-merger integration is something available, meaning that after the acquisition and the transition to the business stabilized, that period is considered to be extremely important. So monitoring is sufficient, and periodically, the reports are made. And for the quarterly report, is -- we receive the quarter report within the Board of Directors' meeting. In business development, the corporate strategic plan is always taken into consideration and the alignment with that is always the important factor to make a decision. Therefore, monitoring and also supervising are firmly taking place. As for the impairment loss, that is something we have to bear because of the nature of pharmaceutical industry. But of course, we do the monitoring and supervising for this.
Unknown Analyst
analystBecause you are the company with a high expectation from the community, so it will be great if you do monitoring. And Sekiyama-san, you are from the trading company. So I believe you are quite strong about the projects and such. So thank you very much, I'm counting on you. May ask another question. This is a question to Sakurai-san. I looked at your background, Sumitomo Mitsui and also Kao's Outside Director are the positions you're serving for representative companies in Japan. Sustainability, or rather diversity, at Astellas, in terms of the active role to be played by female employees, what are the challenges and what is functioning well in your view? That's all my questions.
Eriko Sakurai
executiveThank you for your question. I am serving as an Outside Director. My name is Sakurai. Regarding the diversity, I am asked to share my view on diversity on various occasions. The most important thing is, in the short term, instead of just having a certain number in the short term, but in the longer term, in the culture of the company, it must be incorporated into the organizational culture in the longer term. I associate with various companies, and I worked for a U.S.-based global company for a long time. So I feel that the company may be headquartered in Japan but do global businesses. There are many such companies. But compared to Astellas -- Astellas has a global process to have -- manage personnel in HR. There is no other company in my view. As Sugita-san explained earlier, nationality, gender is irrelevant. The best talent is brought to certain positions. If this process is working well in the end, as a result, you have diversity as a result. That's one thing. Another important thing is that succession planning. For example, you may tend to choose somebody as your right hand. But Astellas is pushing to search somebody from the entire company. As a member of the Nomination Committee, positions close to the top management, I was involved with the succession planning for those positions. Diverse workforce is available as our next-generation candidates, so that process is very important. The company's way to manage the process, and if there's going to be a change from the culture, diversity would be achieved in the end. So in that sense, Astellas is having great initiatives. That's my assessment.
Unknown Analyst
analystRegarding the Astellas diversity initiatives, I have a high assessment in the pharma industry. So that's all for me.
Operator
operatorNext, Mitsui Sumitomo Trust Asset Management, [ Koguchi-san, ] please?
Unknown Analyst
analystMitsui Sumitomo Trust, [ Koguchi ] is my name. Can you hear me?
Unknown Executive
executiveYes.
Unknown Analyst
analystSo thank you for the presentation materials, and the presentation of PDCA here is working quite well. You made a steady growth and progress here. That is really impressive. All your presentation is quite clear. Thank you so much for your effort. And now based upon that, especially materiality one that is obviously access to health. I was planning to ask you the detailed number, but the Page 12, the -- are detailed disclosure of the numbers, so I don't need to ask questions about that. So such a continuous disclosure of the information is really appreciated, because I can check the situation with that. Thank you so much for your cooperation. Now for the partnership. Partnering is quite difficult, especially if the direction is toward the developing countries. For the mega pharma, they are talking about the resource, financial resources and also political situations. So they are paying so much of the attention for that type of the business. But you, as Astellas, what is the current challenge that you are working for? Qualitative information will be fine. But probably, this is a question to Iino-san.
Unknown Executive
executiveThank you for your question. Iino is going to answer for that, Koguchi-san.
Shingo Iino
executiveRegarding partnership. Last fiscal year, newly-formed programs were introduced as the major topic for access to health. Now, only Astellas alone, things will be difficult. So NGO, NPO organizations are what we are cooperating with for these ones. We established RFP, and there, our business, our strength and the capabilities. If they can be made use fully, that is always the criteria to make a decision of the selection. So we clarify what we really want to do, and based upon those clarified, we can come up with the RFP and related NPO and NGO are contacted, and we'll wait for the proposals from them. And we are going to have the discussions for those proposals and make a decision based upon certain criteria. Within this sustainability business unit, we'll select their projects, but that alone might be prone to the risk. So cross-functionally, there is a sustainability advisory panel where the head of each division attend and the discussion will take place to -- so that we do not miss any problems. And this will be brought to the management meeting or the Board of Directors, in other words, where we receive the opinions from them for the very final decision-making. Therefore, at this moment, there was no particular problems that we've experienced. We received the very effective support, and continuously, we would like to conduct our impact of activities.
Unknown Analyst
analystIt will be great if you are very proactive for the improvement. May I ask another question because today, we have 2 outside directors. Sakurai-san earlier talked about the succession planning, which she thinks is important. This time, Yasukawa-san, Okamura-san, are to be promoted, according to the recent announcement. The process up to this, how did you think and how did you reach this decision in the Nomination Committee? Yasukawa-san, Okamura-san shared their views in the news conferences, but what about the view of the Nomination Committee? I'd like to know. And also, Sakurai-san is a female outside director. I hope you will serve as a role model for people inside so that female employees can strive to change the culture in the mid to long-term. I hope that you will go internally to promote diversity within the company, and I'd like to hear your view. So those are my 2 questions.
Mamoru Sekiyama
executiveSekiyama speaking. Okamura-san is now nominated the next President. As the Chairperson of the Nomination Committee, I'd like to explain. At Astellas, every year, at the Nomination Committee, the succession candidates and the succession plannings are being discussed. Regarding Okamura-san, in the Nomination Committee last year from Yasukawa-san, he wanted to recommend him as his successor. There were discussions in the Nomination Committee in the Board of Directors meeting. On the 6th of February, a decision was made. There are appointment standards for Astellas. And from that perspective of the standards and also the management environment and the management strategies, these 2 issues were fully discussed. And that's the standard. There was a sufficient explanation from Dr. Yasukawa, and we also discussed to make this decision. From the perspective of the appointment standards, because of the availability of the standards, you have to look into the future to think about the business environment and the future direction. And because of his capability to be able to respond flexibly and looking at the entire Astellas organization to make decisions, he can do so. And to internal and external stakeholders, he can communicate actively. He can be fully accountable. That's a very important point seen from the Nomination Committee. And he has won the trust for many employees. From the appointment standards perspective, everybody agreed. And Dr. Yasukawa explained the details from the business environment and the business strategy perspective. Mr. Okamura is in charge of finance and also the strategy -- and also strategy implementation. He has a broad range of experiences, and he is fully knowledgeable about the drug discovery business as well. And based on CSP 2021, he can address the transforming environment to pursue innovations, and looking to the future to lead Astellas into the future. According to Dr. Yasukawa, he is appropriate from that perspective, from the appointment standards and also from the business environment and the business strategies. We had a discussion at the Board of Directors meeting, and there were report about the execution. We look at his -- Okamura's leadership, his track record and his character, and the Nomination Committee judged that he is the best candidate as the successor. That's the background.
Unknown Analyst
analystWell understood. Sakurai-san, what do you think?
Eriko Sakurai
executiveThank you for the question. of course, I don't know if I am a good role model or not. But definitely, I would like to make a contribution that is possible to be done by myself. And HR people in this company is quite open. The other day in the Board of Director meetings, I asked about the engagement. And under Sugita-san, there is a female talent manager, and she wanted to talk directly with me. Therefore, I had the web meeting for 1 hour already. And also, if you might assume who that will be, but actually a younger male employee took the paternity leave, and we discussed about the -- how to take care of the kids there as well. So we have a very -- such a close discussion and communication taking place with the employees, so I would like to always find the opportunity that I can make a contribution. That's all.
Operator
operatorNow Daiwa Securities, Hashiguchi-san, please?
Kazuaki Hashiguchi
analystHashiguchi is my name. There are 2 questions. First is about the people and organization. Sugita-san, thank you for your presentation, and I have a very good impression. You are heading towards the very favorable direction. But couple of years ago, compared to Astellas around that time, what you're doing is really an acceleration of the activities to realize the reform. And just like the other Japanese companies, I believe that you have many employees working here for a long time, and what often happens in other companies is that suppose you are doing that you're supposed to do, but if that speed is too accelerated, there are people who cannot catch up with it. That's why motivation is degraded, and they find themselves difficult to find a place within the company. So there is a certain level of the side effects also would take place. But -- so that the people follow this direction and so that you can extract more capabilities of the employees, what kind of thoughtfulness have you applied, or what kind of work are you doing to prepare the environment?
Katsuyoshi Sugita
executiveJust like -- I think what you mentioned is quite right. Yes, we are working on the transformation in a very accelerated manner, and the current speed is really fast. That's what I myself also feel. And there are 2 things I would like to mention. Well, first of all, we are trying to accelerate this transformation now. That's because the speed and the momentums are important for the reform. Otherwise, a change would be quite difficult. Of course, I would like -- we would like to spend in time for this and taking time, but now is the time to make use of this momentum. There is a certain pain of difficulty, but we would like to spend that period in a very short and go quickly to the next phase. So we are conscious that not spending so much of time on this stage. And another point is that, as has been pointed out, there are some who couldn't fully understand this situation, especially about the background and the reason why we are doing. Well, I didn't ask -- talk about this time, but Ask Me Anything Sessions have been repeatedly conducted in our company. Any employee can join this, and especially the -- Okamura and other management people directly answer the questions from the employees. The questions of the employees can be anonymous. They can ask any types of the questions, and those are differently answered. We've been quite persistent about doing these activities. In this situation, again, the reform and speed is quite quick for this reform. So there, we are trying to accommodate the mind or the feeling of those employees facing difficulties. And another point I'd like to add is about engagement survey that I mentioned. The biggest reason for conducting engagement survey is especially at the critical time of the transformation, we need to know the level of the catching up of the employees with this transformation. If they are falling off from this direction, then we have to do something. So plan to see, those are definitely what we are doing. So those 3 are what we are considering.
Kenji Yasukawa
executiveYasukawa speaking, I'd like to add. Ask Me Anything session, there are several ways we can do this. First, we set the theme first, and all questions related to the theme can be asked. It's quite a large session. Another 1 is a group of 20,30 with a smaller group of people. Until they can ask all the questions they want to ask, we would continue a dialogue with a group of 20 to 30 people. Combining the 2 would be the most effective in my view. And also, new employees joined the company every year, and there are mid-career employees who would join our company in the middle of the year. They don't know the past history of the company. When we say CSP, suddenly, this is the transformation Astellas is working on. Even if they're told so, they wonder why this is ongoing. They don't understand why it's important. So a few times a year, I meet with mid-career employees -- mid-career hires, by explaining the past history and background. We talk about the CSP and the measures we are taking, and what's the background for that. I explain those points to them, and then they can facilitate their understanding.
Kazuaki Hashiguchi
analystWell understood. One more question. This is different from today's theme, but in 2050, you'd like to achieve a net zero for the greenhouse gas emissions. A year ago, you showed the direction, but you said that you were discussing the details for your measures. A week ago, you made a decision according to the press release. For the past year, what did you discuss over the past year in this regard? A year ago, you don't know whether you can do this, so you didn't make a declaration. But now, you are declaring, so you see a path for the future. That's what I thought. Is my understanding correct? This is not something to be done competitively. What you're working on or the issues you face and the lessons learned can be shared with the society at large. This could be leveraged in the initiatives by other companies as well, so there can be proactive output and explanation to outside, which I think is important. What's your view on this?
Kenji Yasukawa
executiveSo Iino is going to respond to your first question.
Shingo Iino
executiveCompared to a year ago until now, yes, you're right. Net zero by 2050 was declared by us. Is that going to be feasible? We discussed whether this is going to be feasible or not very carefully. Scope 1, 2, 3 are set within each scope. What kind of measures you can take? What is the current status, and what's missing right now? We discussed these details by now. In that process, Scope 1, hybrid cars and EV, electric vehicles are used by salespeople. We are thinking of such introductions in Japan and in the United States. This is already done like 80%, but in Europe, it's still around 10% or so, so we're going to address this issue in Europe to cover this. As for Scope 2, renewable energy-derived power, we're going to switch to that. The issue is Scope 3. We alone cannot achieve the target. We need the understanding of the suppliers. We alone would face difficulties, so beyond the border of a single company with various people in different industries as well as the other companies in the same industries, what approach we should take will be discussed. The second point is that environmental issue is the issue throughout the world and within Keidanren as well, this is also touched upon. I had a certain opportunity to -- so when I have a chance to speak out, I always introduce our activities by Astellas, not only domestically but Ireland plant situation has been introduced to the people in Keidanren as well. That's all.
Operator
operatorNext, Nikkei Newspaper, Yamada-san, please.
Unknown Analyst
analystThere are 2 questions from me. This is a question to Sekiyama-san. CSP, I refer to that, and that is well made. That's my impression. But the voices and opinions from external directors, how that is reflected and where? From the outside perspective, I believe that you need to -- you think that it is necessary to incorporate set of factors, and where are they? And the kind of plan is ongoing for the execution, but in the situation, what is better to be improved from the [ outside ] director's perspective, especially regarding the monitoring also?
Mamoru Sekiyama
executiveSo CSP '18 and 2021, for 2 times, I experienced the corporate strategy plan. For CSP '21, from the draft-making stages, I've been invited for the Board of Directors, and we had so much of the discussions. We had the 3-year of the CSP 2018, and basic policies are also inherited within CSP 2021, thus the CSP '21 is generated. The direction is taking the risks in a very proactive manner. In order to realize that, the organizational healthiness target is considered to be important. That is considered. And 1 proposal that we made as external director is a fourth strategic target that is a sustainability. In the beginning, there was a bit of the delay of that within Astellas for the sustainability. The disclosure was behind, but the sustainability is a very important managerial issues and challenge, so that has to be well worked on. And sustainability leads to the corporate value, therefore, it is necessary to disclose that aspects outside. And with that non-financial value, it's possible to be introduced and the value itself can be enhanced. That is where the external directors made opinion and that was actually incorporated, and that's why we are having this kind of meeting this time. That's 1 thing. That's 1 of the important things that I've realized. And the other is monitoring. The request is to conduct in the monitoring. As it's been explained every time, there are 4 strategic target. Every 3 months, the detailed monitoring and also the business report are taking place. So we have good understanding and we placed our comments as well. That's all.
Kenji Yasukawa
executiveYasukawa speaking, I'd like to add on the last point. On behalf of the executive team, the President and CEO every quarter, 4 times a year, what is the progress of CSP? That is reported to the Board of Directors by the President. CSP 2021, since that, we changed the way substantially before in the past. As many companies are doing, this is what our research drug discovery division did, and this is what the development people did, this is what the sales people did. We discontinued in such a way, and CSP 2021 strategic goals, 1, 2, 3, 4 are segmented into detail. So regarding strategic goal 1-1, this is the quarterly progress. Strategic goal 2, this is the progress. So we make a progress report not by division, but based on the strategy. We make a report in that way to the Board of Directors, whether the strategy itself is working or not must be clear to them, and the issues identified can be discussed in a deeper fashion. That's what we are doing right now.
Unknown Analyst
analystWell understood. One more question to Sekiyama-san about the compensation. Comparing to mega pharmas overseas, the compensation level, if you benchmark, you may be using the overseas mega pharmas compensation as a benchmark. But if you look and compare between U.S. and Japan, there may be a gap in the compensation level, and the very expensive compensation levels might be criticized in Japan. In order to secure good talent, an appropriate compensation level has been achieved. I'd like to hear from you on this occasion.
Mamoru Sekiyama
executiveAs the Nomination Committee, we had a major revision in 2019 and the policy and the system and the level of the compensation were changed. Regarding the number -- the level, as you explained, Japanese manufacturers were used as comparators, as benchmarking to determine the compensation for directors and officers. But if you look at the mega pharmas in the Western countries, we also wanted to reference their level as well, just for reference. There's still a big gap, but we refer to that for reference. So that we can be one of such companies. That's how we are discussing every time. So mega pharma with revenues of 0.5x or twice as much compared to us, such mega pharmas are selected for comparison. And we may compare against European mega pharmas so that we can be at a similar level compared to their business.
Unknown Analyst
analystRegarding this question, Sugita also would like to add.
Katsuyoshi Sugita
executiveAs Sekiyama-san said, we -- every year, captures benchmarking data. Domestic companies' benchmarking is being done, but we also do benchmarking against overseas companies as well. Needless to say, the size of the sales and revenues must be within the comparable range for us so that we can benchmark, and we try to be as aggressive as possible in setting compensation so that we can acquire the best talent in the world. Right now, the wage gap does exist among different countries, so that's -- may be reflected from the local market respectively, but we'd like to acquire the best talent on a global basis as much as possible. So we do benchmarking not only in Japan, but also overseas as well. That's all for me.
Mamoru Sekiyama
executiveSo Japanese companies or manufacturer can be set as a benchmark. But this industry, the competition is on a global basis, so you have to introduce the people who is capable to win the competition in overseas market or the global market as well.
Hiromitsu "Hiro" Ikeda
executiveThank you so much. It's about the time to close. Today, everyone, thank you so much for your participation in this sustainability meeting. Continuously would like to enhance our approach for the dialogue with the stock market community, so in advance, thank you so much for your support and cooperation.
This call discussed
For developers and AI pipelines
Programmatic access to Astellas Pharma Inc. earnings transcripts and 32,000+ others is available through the
EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.